pharmaceuticals

Trump says US will soon announce tariff on pharmaceutical imports

by

Trump’s New Tariffs: A Game-Changer for the Pharmaceutical Industry? President Donald Trump recently announced plans to introduce a “major” tariff on pharmaceutical imports, marking a significant development in the global pharmaceutical landscape. These tariffs, designed to encourage drug companies to relocate their operations to the United States, could potentially reshape the industry’s geographical dynamics. The … Read more

Expanding Rapid Recovery Close to Home: Robotic-Assisted Joint Replacement Surgery

by

The Rise of Robotic-Assisted Joint Replacement Surgery As technology advances, robotic-assisted joint replacement surgery is becoming a game-changer in the healthcare industry. These cutting-edge procedures promise higher accuracy, less invasive processes, reduced recovery times, and lower complication risks. The AHN Orthopaedic Institute in western Pennsylvania is at the forefront of this movement, providing same-day surgery … Read more

Rivaroxaban Akin to Warfarin for Left Ventricular Thrombus After MI

by

The Promising Horizon of Anticoagulation: A Look at Rivaroxaban vs. Warfarin Anticoagulants have long played a pivotal role in managing conditions like myocardial infarction (MI) by preventing the formation of dangerous blood clots in the heart. The recent RIVAWAR trial sheds new light on rivaroxaban as a significant contender against warfarin, a standard treatment in … Read more

Donald Trump’s pick for Beijing envoy affirms US commitment to one-China policy

by

Predicting the Future: US-China Strategies and Alliances Unpacking the Strategy for China: “Some Pain Ahead” President Donald Trump’s nominee for ambassador to Beijing, David Perdue, made headlines by indicating that the US strategy regarding China could “involve some pain.” This statement underscores the calculated approach towards China, emphasizing strategic resistance against perceived economic and geopolitical … Read more

Intensive Medical Therapy Does Not Improve Outcomes in Women with INOCA

by

The WARRIOR Trial: A Landmark Study in Women’s Heart Health The recent conclusion of the WARRIOR trial has turned heads in the medical community, particularly among specialists treating ischemia without obstructive coronary artery disease (INOCA). Conducted as the largest randomized, pragmatic outcome trial for INOCA, the study has provided critical insights yet with a nuance … Read more

Prior Oral Anticoagulant Use May Influence Stroke, Bleeding Risk in AF

by

Exploring the Future of Anticoagulant Treatments for Atrial Fibrillation New Insights from OCEANIC-AF Study The recent findings from the Oral Factor 11a Inhibitor Asundexian as Novel Antithrombotic–Atrial Fibrillation (OCEANIC-AF) study opened up new possibilities in treating atrial fibrillation (AF) patients. Atrial fibrillation is a common heart condition led by irregular heartbeats, increasing the risk of … Read more

Novel Lipid Indicator Identifies Risk of Ischemic Heart Disease in T2D

by

Unlocking the Future of Lipid Management in Type 2 Diabetes A groundbreaking investigation has unveiled a potential game-changer in assessing ischemic heart disease (IHD) risks for individuals with type 2 diabetes (T2D): the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR). Led by Sikun Zhang of the Second Xiangya Hospital, this study highlights how … Read more

HCPLive 5 Stories in Under 5: Week of 03/16

by

Future Trends in Healthcare: Insights from Recent Developments Advancements in Migraine Treatment Protocols The recent update from the American College of Physicians (ACP) on adding a triptan to NSAIDs or acetaminophen for treating migraines marks a significant shift in acute migraine management. This combination therapy approach could influence new treatment algorithms across healthcare systems. Clinicians, … Read more

HCPLive 5 Stories in Under 5: Week of 03/09

by

Revolutionizing Weight Management: The Future of CagriSema The recent success of CagriSema in the Phase 3 REDEFINE 2 trial has marked a significant milestone in weight management for individuals with obesity and type 2 diabetes. As CagriSema demonstrated a nearly 16% weight loss, exceeding placebo results, we are poised to see how this regorafenib will … Read more

RFK Jr. could further deter childhood vaccinations as U.S. rates fall

by

Shifting Vaccination Trends: A Look at Current Challenges and Future Implications The landscape of childhood vaccinations in the United States is undergoing significant changes, influenced by new leadership and evolving public perceptions. The recent appointment of Robert F. Kennedy Jr. as the Secretary of Health and Human Services signals potential shifts in policy that could … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]